Nuwellis, Inc. NUWE
At closeNov 4, 2026, 5:18 PM EST
After hours · Nov 4, 5:18 PM ET
- YTD
- -91.35%
- 1 year
- -94.40%
- Market cap
- 2.14M
- Revenue (ttm)
- 9.01M
- Profit margin
- -232.24%
- EPS (ttm)
- 4,592.43
- Shares out
- 4.37M
- P/E ratio
- 0.00
- Forward P/E
- -0.41
- YTD return
- -91.35%
- 1-year return
- -94.40%
- Volume
- 75.46K
- Avg volume
- 834.00K
- Open
- 5.39
- Previous close
- 5.91
- Day's range
- 5.20 – 5.56
- 52-week range
- 2.52 – 1,556.10
- Beta
- 0.36
- Price target
- 16.00 (+203.6%)
5D +1.23 (+26.28%)
Key statistics
- Enterprise value
- 2.30M
- PEG ratio
- 0.00
- Price / sales
- 0.51
- Price / book
- 0.06
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.70%
- Free cash flow
- -12.32M
- Total cash
- 1.02M
- Total debt
- 654.00K
- Return on equity
- -987.45%
- Short % of float
- 17.27%
- 50-day average
- 1.53
- 200-day average
- 5.15
Analyst view
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.88 | 1.74 | +2.62 | +297.73% |
| Aug 13, 2024 | Jun 1, 2024 | -9.49 | -18.85 | -9.36 | -98.63% |
| May 7, 2024 | Mar 1, 2024 | 0.00 | -20.98 | — | — |
| Mar 5, 2024 | Dec 1, 2023 | 0.00 | -78.32 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | -63.29 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -127.62 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | Roth MKM | reit | Buy | Buy |
| Jul 29, 2024 | Roth MKM | init | — | Buy |
| Nov 8, 2023 | Ladenburg Thalmann | down | Buy | Neutral |
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuwellis.com
News
Nuwellis to Report Third Quarter 2026 Financial Results on November 12 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Nuwellis Has Received A Notice Of Allowance For A U.S. Patent Titled "BLOOD FILTRATION SYSTEM WITH INFUSION PUMP STATE DETECTOR". 
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology 
Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in September 
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System 
Nuwellis To Participate In Four Medical Conference This Month To Present Data, Discuss Role Of Its Aquadex SmartFlow System 
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences 
Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short Interest
Your note
Sign in to keep a note on NUWE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JARAMILLO NESTOR JR, | Chief Executive Officer | Purchase | Mar 14, 2023 | 4,098 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.35% | 15,127 | 16.03K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.31% | 13,631 | 14.45K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.15% | 6,346 | 6.73K | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 312 | 330 | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.00% | 1 | 1 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 11 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.17% | 7,478 | 7.93K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 3,189 | 3.38K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 2,759 | 2.92K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 1,426 | 1.51K | Sep 29, 2024 |